🇺🇸 Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI in United States

Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI (Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI in United States?

Orion Corporation, Orion Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.